Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma

Clinical trial NCT03041701 · TERMINATED

Trial details

NCT number: NCT03041701
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Rhabdomyosarcoma Rhabdomyosarcoma, Alveolar Rhabdomyosarcoma, Embryonal

Start date: 2017-07-07
Primary completion: 2021-09-15
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.